1-8 of 8
Christian Hagemeier
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Intermediate-Risk Acute Lymphoblastic Leukemia (ALL) Patients with and without Relapse Differentially Depend on Survival Signals From Microenvironment

Peter Rhein, PhD, Rita Mitlohner, Renate Kirschner-Schwabe, PhD, Christian Hagemeier, MD, PhD, Gunnar Cario, MD, Martin Stanulla, MD, MSc, Martin Schrappe, MD, Iduna Fichtner, PhD, Richard Ratei, MD, Wolf-Dieter Ludwig, Leonid Karawajew, PhD
Journal: Blood
Blood (2011) 118 (21): 752.
https://doi.org/10.1182/blood.V118.21.752.752
Published: 2011
Journal Articles

CD11b is a therapy resistance– and minimal residual disease–specific marker in precursor B-cell acute lymphoblastic leukemia

Peter Rhein, Rita Mitlohner, Giuseppe Basso, Giuseppe Gaipa, Michael N. Dworzak, Renate Kirschner-Schwabe, Christian Hagemeier, Martin Stanulla, Martin Schrappe, Wolf-Dieter Ludwig, Leonid Karawajew, Richard Ratei
Journal: Blood
Blood (2010) 115 (18): 3763–3771.
https://doi.org/10.1182/blood-2009-10-247585
Published: 2010
Journal Articles

Glucocorticoid Therapy Targets Proliferation, Differentiation and Bcl-2 Dependent Survival Signaling in ALL Blasts.

Peter Rhein, Stefanie Scheid, Richard Ratei, MD, Christian Hagemeier, PhD, MD, Karl Seeger, PhD, MD, Renate Kirschner-Schwabe, PhD, Martin Schrappe, MD, Rainer Spang, PhD, Wolf-Dieter Ludwig, MD, Leonid Karawajew, PhD
Journal: Blood
Blood (2006) 108 (11): 1841.
https://doi.org/10.1182/blood.V108.11.1841.1841
Published: 2006
Journal Articles

Classical Hodgkin lymphoma is characterized by high constitutive expression of activating transcription factor 3 (ATF3), which promotes viability of Hodgkin/Reed-Sternberg cells

Martin Janz, Michael Hummel, Matthias Truss, Brigitte Wollert-Wulf, Stephan Mathas, Korinna Jöhrens, Christian Hagemeier, Kurt Bommert, Harald Stein, Bernd Dörken, Ralf C. Bargou
Journal: Blood
Blood (2006) 107 (6): 2536–2539.
https://doi.org/10.1182/blood-2005-07-2694
Published: 2006
Includes: Supplemental data
Journal Articles

Gene Expression in Leukemic Blasts Persisting at Day 8 of Induction Therapy in Childhood ALL Displays a Common Shift towards Terminally Differentiated B Cells and a Cytoreduction-Associated Impairment of the Translational Machinery.

Peter Rhein, Stefanie Scheid, Richard Ratei, MD, Christian Hagemeier, PhD, MD, Karl Seeger, PhD, MD, Renate Kirschner-Schwabe, PhD, Martin Schrappe, MD, Rainer Spang, PhD, Wolf-Dieter Ludwig, MD, Leonid Karawajew, PhD
Journal: Blood
Blood (2005) 106 (11): 537.
https://doi.org/10.1182/blood.V106.11.537.537
Published: 2005
Journal Articles

Gene Expression Analysis of Leukemic Blasts Persisting at Day 8 of Induction Therapy in Childhood ALL.

Peter Rhein, Richard Ratei, Stefanie Scheid, Christian Hagemeier, Karl Seeger, Renate Kirschner, Martin Schrappe, Rainer Spang, Wolf-Dieter Ludwig, Leonid Karawajew
Journal: Blood
Blood (2004) 104 (11): 522.
https://doi.org/10.1182/blood.V104.11.522.522
Published: 2004
Journal Articles

Differential Gene Expression in Leukemic Cells from Bone Marrow (BM) and Peripheral Blood (PB) of Pediatric Patients with Acute Lymphoblastic Leukemia (ALL).

Peter Rhein, Stefanie Scheid, Christian Hagemeier, Karl Seeger, Renate Kirschner, Martin Schrappe, Rainer Spang, Wolf-Dieter Ludwig, Leonid Karawajew
Journal: Blood
Blood (2004) 104 (11): 1889.
https://doi.org/10.1182/blood.V104.11.1889.1889
Published: 2004
Journal Articles

Hydrolytically activated etoposide prodrugs inhibit MDR-1 function and eradicate established MDR-1 multidrug-resistant T-cell leukemia

Ulrike Schroeder, Kathrin M. Bernt, Björn Lange, Jens Wenkel, Jiang Jikai, Doron Shabat, Roey Amir, Nicole Huebener, Andreas G. Niethammer, Christian Hagemeier, Lüder Wiebusch, Gerhard Gaedicke, Wolfgang Wrasidlo, Ralph A. Reisfeld, Holger N. Lode
Journal: Blood
Blood (2003) 102 (1): 246–253.
https://doi.org/10.1182/blood-2002-07-2268
Published: 2003